- Home
- SPT vs DNA Comparison
SPT vs DNA Comparison
Compare SPT & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPT
- DNA
- Stock Information
- Founded
- SPT 2010
- DNA 2008
- Country
- SPT United States
- DNA United States
- Employees
- SPT 1322
- DNA N/A
- Industry
- SPT Computer Software: Prepackaged Software
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPT Technology
- DNA Health Care
- Exchange
- SPT Nasdaq
- DNA Nasdaq
- Market Cap
- SPT 687.5M
- DNA 731.1M
- IPO Year
- SPT 2019
- DNA N/A
- Fundamental
- Price
- SPT $11.06
- DNA $13.88
- Analyst Decision
- SPT Buy
- DNA Strong Sell
- Analyst Count
- SPT 10
- DNA 1
- Target Price
- SPT $27.70
- DNA $9.00
- AVG Volume (30 Days)
- SPT 1.4M
- DNA 1.7M
- Earning Date
- SPT 11-05-2025
- DNA 11-11-2025
- Dividend Yield
- SPT N/A
- DNA N/A
- EPS Growth
- SPT N/A
- DNA N/A
- EPS
- SPT N/A
- DNA N/A
- Revenue
- SPT $430,795,000.00
- DNA $230,815,000.00
- Revenue This Year
- SPT $13.14
- DNA N/A
- Revenue Next Year
- SPT $11.88
- DNA $14.41
- P/E Ratio
- SPT N/A
- DNA N/A
- Revenue Growth
- SPT 14.79
- DNA 25.21
- 52 Week Low
- SPT $11.51
- DNA $5.00
- 52 Week High
- SPT $36.30
- DNA $17.58
- Technical
- Relative Strength Index (RSI)
- SPT 22.11
- DNA 52.86
- Support Level
- SPT $12.27
- DNA $14.63
- Resistance Level
- SPT $11.88
- DNA $17.58
- Average True Range (ATR)
- SPT 0.53
- DNA 1.33
- MACD
- SPT -0.12
- DNA 0.16
- Stochastic Oscillator
- SPT 1.50
- DNA 46.60
About SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.